FDA mulls subjecting metal hip implants to tougher oversight

01/18/2013 | Reuters · Wall Street Journal, The

The FDA has proposed requiring makers of metal-on-metal hip implants to submit additional data to back the safety and effectiveness of their devices in order to continue marketing them. The move is spurred by concerns that the devices can lead to soft-tissue damage and may require replacement surgery.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA